MedPath

Assessment of malignant diseases post kidney transplantation at the University Hospital Leipzig

Recruiting
Conditions
Z94.0
C80
Malignant neoplasm, without specification of site
Kidney transplant status
Registration Number
DRKS00021669
Lead Sponsor
niversitätsklinikum Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Kidney transplantation

Exclusion Criteria

less than 18 years of age; hematopoietic stem cell transplantation

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Statistical determination of prevalence including time point of onset (primary endpoint) of malignant disease after kidney transplantation (Ktx) at the University of Leipzig Medical Center in a retrospective analysis via electronic health records and updated information from clinical questionnaires.
Secondary Outcome Measures
NameTimeMethod
Evaluation of a hereditary / genetic cause and susceptibility of malignant disease after renal transplantation via molecular genetic analysis.
© Copyright 2025. All Rights Reserved by MedPath